ASCO26: Michael Hassett, MD, MPH, eSyM - Summary - MDSpire

ASCO26: Michael Hassett, MD, MPH, eSyM

Dr. Michael Hassett of Dana-Farber Cancer Institute shared new findings showing deployment of eSyM, an ePRO-based, EHR-integrated symptom management program, was associated with statistically significant and potentially meaningful improvements in overall survival. Strategies to improve adoption of ePRO-based symptom management may be warranted.

  • July 1, 2026

Share

Objective:

To present findings on the deployment of an ePRO-based symptom management program integrated with EHR.

Approach:
  • Study Overview: Dr. Michael Hassett discussed the implementation of eSyM, a symptom management program.
Key Findings:
  • Deployment of eSyM was associated with statistically significant improvements in overall survival.
Interpretation:

Strategies to enhance the adoption of ePRO-based symptom management may be necessary.

Conclusion:

Original Source(s)

ASCO26: Michael Hassett, MD, MPH, eSyM

  • July 1, 2026

Related Content

Development and application of a prognostic model based on radiomics and artificial intelligence for patients with lung adenocarcinoma brain metastasis

Optimizing immunotherapy in advanced gastric cancer: established and emerging biomarkers for precision patient selection

Bladder metastasis from gastric cancer presenting as acute post-renal obstruction during immunotherapy: a case report